Table 4.

CCNG1 expression and clinicopathological features in human high‐grade serous ovarian cancer (HGSOC) patients

Groups	n	Low expression	High expression	P‐value
Age (y)
>50	89	33	56	0.790
=<50	177	70	107
FIGO stage
I	22	7	15	0.756
II	29	11	18
III+IV	214	85	129
Unknown	1	0	1
OS (y)
>2	176	77	99	0.0240
=<2	53	17	46
Unknown	27	9	18
PFS (y)
>2	139	65	74	<0.0001
=<2	77	16	61
Unknown	50	28	22